HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John van Duzer Selected Research

KRM 1648

10/2007Rifalazil and other benzoxazinorifamycins in the treatment of chlamydia-based persistent infections.
11/2006Efficacy of novel rifamycin derivatives against rifamycin-sensitive and -resistant Staphylococcus aureus isolates in murine models of infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John van Duzer Research Topics

Disease

1Inborn Genetic Diseases (Disease, Hereditary)
11/2019
1Ototoxicity
11/2019
1Peripheral Arterial Disease
10/2007
1Persistent Infection
10/2007
1Atherosclerotic Plaque (Atheroma)
10/2007
1Infections
11/2006
1Body Weight (Weight, Body)
11/2006
1Sepsis (Septicemia)
11/2006
1Hyperalgesia
02/2005
1Arthritis (Polyarthritis)
02/2005
1Ulcer
02/2005

Drug/Important Bio-Agent (IBA)

2KRM 1648IBA
10/2007 - 11/2006
1ELX-02IBA
11/2019
1Nonsense Codon (Nonsense Mutation)IBA
11/2019
1Pharmaceutical PreparationsIBA
11/2019
1Rifampin (Rifampicin)FDA LinkGeneric
11/2006
1RifamycinsIBA
11/2006
1lumiracoxib (prexige)IBA
02/2005
1Diclofenac (SR 38)FDA LinkGeneric
02/2005

Therapy/Procedure

2Therapeutics
11/2019 - 11/2006